Immunome (IMNM) Current Deferred Revenue (2023 - 2025)
Immunome (IMNM) posted Current Deferred Revenue of $4.0 million for Q1 2025, down 42.16% on a QoQ basis from $6.9 million in Q4 2024, and down 68.5% year-over-year from $12.7 million in Q1 2024.
Immunome (IMNM) Current Deferred Revenue (2023 - 2025) Analysis & Trends
Immunome's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2025.
- Quarterly Current Deferred Revenue fell 68.5% year-over-year to $4.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $4.0 million (down 68.5% YoY) and the FY2024 annual result came in at $6.9 million, down 56.57% from the prior year.
- Current Deferred Revenue was $4.0 million for Q1 2025 at Immunome, down from $6.9 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $27.6 million in Q1 2023 and bottomed at $4.0 million in Q1 2025.
- A 3-year average of $14.4 million and a median of $12.7 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue sank 42.92% — and 2025, when it sank 68.5%.
- Immunome's Current Deferred Revenue stood at $16.0 million in 2023, then slumped by 56.57% to $6.9 million in 2024, then sank by 42.16% to $4.0 million in 2025.
- Business Quant data shows IMNM's Current Deferred Revenue at $4.0 million in Q1 2025, $6.9 million in Q4 2024, and $9.7 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | 6.94 Mn |
| Sep 30, 2024 | 9.68 Mn |
| Jun 30, 2024 | 12.59 Mn |
| Mar 31, 2024 | 12.75 Mn |
| Dec 31, 2023 | 15.98 Mn |
| Sep 30, 2023 | 16.96 Mn |
| Jun 30, 2023 | 23.37 Mn |
| Mar 31, 2023 | 27.64 Mn |